Nordhealth reaches EUR53.1 million signed ARR as Q3 EBITDA turns positive
AI Summary- Nordhealth reached EUR53.1 million in signed ARR at Q3 2026.
- EUR1.3 million was Q3 adjusted EBITDA minus CapEx, up EUR1.5 million year over year.
- Therapy migrations and German localization remained incomplete at the end of Q3.